AstraZeneca recently announced that it is enhancing its response to the current pandemic and collaborating with multiple countries and organizations to make the University of Oxford’s COVID-19...
The Trump Administration recently released framework and leadership for Operation Warp Speed (OWS), a new program designed to accelerate the development, manufacturing, and distribution of COVID-19...
FDA recently issued the first emergency use authorization (EUA) for a COVID-19 antigen test for use during the pandemic.
For more coronavirus updates, visit our resource page, updated twice...
Office of the Assistant Secretary for Preparedness and Response (ASPR) at HHS recently announced the allocation plan for remdesivir, a COVID-19 treatment for hospitalized patients.
For more...
Using two different alternative pricing models, the Institute for Clinical and Economic Review (ICER) determined that the price for remdesivir could range from $10 to over $4,000.
For more coronavirus...
FDA recently granted emergency use authorization (EUA) to Gilead for the investigational antiviral, remdesivir, to treat COVID-19 patients.
For more coronavirus updates, visit our resource...
Pfizer and BioNtech recently announced that the first participants have been dosed in a Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19.
For more coronavirus updates, visit...
Premier Inc recently found that drug shortages to treat cardiovascular conditions have increased due to the COVID-19 pandemic, according to a press release.
For more coronavirus updates, visit...
Merck estimates that the novel coronavirus outbreak will decrease the company’s 2020 revenues by over $2 billion as social distancing and other precautions impact business, according to the...
Sanofi recently announced that FDA approved a biologics license application for a MenQuadfi meningococcal (Groups A, C, Y, W) conjugate vaccine for the prevention of meningitis in individuals two...
Johnson & Johnson (J&J) recently announced a collaboration between Janssen Pharmaceuticals and Emergent BioSolutions to support the manufacturing of its lead investigational COVID-19 vaccine...
Bristol Myers Squibb and Exelixis Inc recently announced that CheckMate- 9ER, a pivotal Phase 3 clinical trial evaluating two drugs, showed positive results against untreated kidney cancer...
Pfizer and BioNTech recently disclosed additional details on their COVID-19 vaccine development plans through BioNTech’s and mRNA vaccine program.
For more coronavirus updates, visit...
Novartis recently announced its commitment to donate up to 130 million doses of generic hydroxychloroquine, a potential COVID-19 treatment.
For more coronavirus updates, visit our resource...
Sanofi and GSK recently announced that they signed a letter of intent to develop an adjuvanted COVID-19 vaccine.
For more coronavirus updates, visit our resource page, updated twice daily...
Eli Lilly and Company recently launched a program allowing anyone with or without commercial insurance to fill their monthly prescription of Lilly insulin for $35, boosting patient access to insulin...
A clinical trial to evaluate the safety and efficacy of hydroxychloroquine for the treatment of hospitalized adult COVID-19 patients has begun, according to a recent press release from the National...
Henry Ford Health System will lead the first large-scale study in the US to determine the effectiveness of hydroxychloroquine in preventing COVID-19 among healthcare workers and first...
The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more...
When matched for all characteristics, two biosimilars showed significant cost savings for large US employers, according to researchers from the Bloomberg School of Public Health at Johns Hopkins...
